Evidence map›Paper›PMID 38003341›Full record

ArticleInternational journal of molecular sciences2023

Marko Markovic, Jovan Ranin, Zoran Bukumiric, Djurdja Jerotic, Ana Savic-Radojevic, Marija Pljesa-Ercegovac, Tatjana Djukic, Marko Ercegovac, Milika Asanin, Ivana Milosevic and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Marko MarkovicClinic of Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0002-3574-3341
Jovan RaninClinic of Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0398-9486
Zoran BukumiricFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-7609-4504
Djurdja JeroticFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1664-6557
Ana Savic-RadojevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2026-4180
Marija Pljesa-ErcegovacFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8969-0594
Tatjana DjukicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1959-5115
Marko ErcegovacFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Milika AsaninFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Ivana MilosevicClinic of Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-4331-3328
Goran StevanovicClinic of Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.
Tatjana SimicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8683-5129
Vesna CoricFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0227-821X
Marija MaticFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
University of Belgrade · RSSerbian Academy of Sciences and Arts · RS

Funding

Science Fund of the Republic of Serbia Antioxidentification No7546803
6 · The paper itself

Abstract

In SARS-CoV-2 infection, excessive activation of the immune system intensively increases reactive oxygen species levels, causing harmful hyperinflammatory and oxidative state cumulative effects which may contribute to COVID-19 severity. Therefore, we assumed that antioxidant genetic profile, independently and complemented with laboratory markers, modulates COVID-19 severity. The study included 265 COVID-19 patients. Polymorphism of G

Indexed as

COVID-19FibrinogenGenotypeGlutathione PeroxidaseGlutathione TransferaseHumansPolymorphism, GeneticSARS-CoV-2FibrinogenGlutathione PeroxidaseGlutathione TransferaseGPX3 protein, humanGSTO1 protein, humanantioxidant genetic profileCOVID-19disease progressionGPX3inflammatory markersoxidative stress

Identifiers

PMID38003341
PMCPMC10671662
OpenAlexW4388570970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.